VRDN
#1923
Viridian Therapeutics, Inc. - Common Stock
18.3 0 USD
-0.02%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.93%
Variazione Mensile
-14.76%
Variazione di 6 mesi
+22.24%
Variazione Annuale
-18.49%
Chiusura Precedente
18.6 6
Open
19.0 0
Minimo
18.2 1
Massimo
19.1 9
Financials
2021
Quarterly report, Q3 FY2021
Viridian Therapeutics, Inc. quarterly report, Q3 FY2021
10-Q
Current report, 20 Sep 2021
Viridian Therapeutics, Inc. current report, 20 September 2021
8-K
Current report, 11 Aug 2021
Viridian Therapeutics, Inc. current report, 11 August 2021
8-K
Current report, 26 Jul 2021
Viridian Therapeutics, Inc. current report, 26 July 2021
8-K
Current report, 14 Jul 2021
Viridian Therapeutics, Inc. current report, 14 July 2021
8-K
Quarterly report, Q2 FY2021
Viridian Therapeutics, Inc. quarterly report, Q2 FY2021
10-Q
Current report, 03 Jun 2021
Viridian Therapeutics, Inc. current report, 03 June 2021
8-K
Current report, 14 May 2021
Viridian Therapeutics, Inc. current report, 14 May 2021
8-K
Current report, 06 May 2021
Viridian Therapeutics, Inc. current report, 06 May 2021
8-K
Current report, 23 Apr 2021
Viridian Therapeutics, Inc. current report, 23 April 2021
8-K